financetom
Business
financetom
/
Business
/
PetVivo Names Garry Lowenthal its New Chief Financial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PetVivo Names Garry Lowenthal its New Chief Financial Officer
Mar 11, 2024 6:13 AM

08:46 AM EDT, 03/11/2024 (MT Newswires) -- PetVivo Holdings ( PETV ) said Monday it has named Garry Lowenthal its new chief financial officer.

Lowenthal has served as Managing Partner of Security First International, a CFO advisory and management consulting firm, and in positions at PricewaterhouseCoopers and Deloitte.

PetVivo ( PETV ) is a veterinary biotech device and therapeutics company.

Price: 1.1, Change: +0.02, Percent Change: +1.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enphase Energy to lay off 17% of workforce
Enphase Energy to lay off 17% of workforce
Nov 9, 2024
(Reuters) -Enphase Energy will cut its global workforce by about 17%, impacting about 500 employees and contractors, the solar inverter maker disclosed in a filing on Friday. Enphase will also streamline its operations by focusing contract manufacturing in four existing locations - two in the United States, one in India and one in China. The company will cease its contract...
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Moog Insider Sold Shares Worth $298,979, According to a Recent SEC Filing
Nov 9, 2024
04:01 PM EST, 11/08/2024 (MT Newswires) -- Brian J Lipke, Director, on November 07, 2024, sold 1,343 shares in Moog ( MOG/A ) (MOGA, MOGB) for $298,979. Following the Form 4 filing with the SEC, Lipke has control over a total of 19,765 shares of the company, with 19,765 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/67887/000006788724000085/xslF345X05/wk-form4_1731099060.xml ...
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing
Nov 9, 2024
04:23 PM EST, 11/08/2024 (MT Newswires) -- Giuseppe Ciaramella, President, on November 06, 2024, sold 51,110 shares in Beam Therapeutics ( BEAM ) for $1,347,050. Following the Form 4 filing with the SEC, Ciaramella has control over a total of 109,150 shares of the company, with 109,150 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1745999/000095017024124085/xslF345X05/ownership.xml ...
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Fate Therapeutics Reports Positive Preclinical Data for Cancer Treatment Candidate
Nov 9, 2024
04:53 PM EST, 11/08/2024 (MT Newswires) -- Fate Therapeutics ( FATE ) said late Friday that preclinical data for its CAR T-cell candidate FT836 demonstrated the product's potential for durable anti-tumor activity without intervention. The data support the pan-cancer activity of MICA/B targeting, and indicate that our next-generation, iPSC-derived CAR T-cell platform has the potential to drive potent and durable...
Copyright 2023-2026 - www.financetom.com All Rights Reserved